infectious-diseases-2016_posters-accepted-abstracts

3 / 30

Volume 4, Issue 4(Suppl) J Infect Dis Ther 2016
ISSN: 2332-0877, JIDT an open access journal
Page 85
Notes:
Infectious Diseases 2016
August 24-26, 2016
conferenceseries.com
August 24-26, 2016 Philadelphia, USA
&
Infectious DiseasesJoint Event on 2nd World Congress on
Pediatric Care & Pediatric Infectious Diseases
International Conference on
Detection of Beijing genotype of MDR M. tuberculosis by targeting Rv2820 gene and their
association with drug resistance mutations in katG, rpoB and embB
Anamika Gupta
Boston University School of Medicine, USA
Beijing genotype of Mycobacterium tuberculosis has attracted special attention due to its association with multi drug resistance and
rapid transmission. The present study was undertaken to investigate the prevalence of Beijing genotype of M. tuberculosis and
their association with drug resistance and clinical characteristics of TB patients. A total of 381 clinical isolates were cultured from
more than 4000 TB patients’ sputum samples from 2008 to 2014, of which the genetic profile was determined by using multiplex-PCR
and Spoligotyping methods and the drug susceptibility testing to first-line anti-TB drugs was performed by using proportion method
and MGIT960. Detection of mutations at rpoB codons (516, 526 and 531), katG codon 315 and embB codon 306 in Beijing and non-
Beijing-strains were determined by MAS-PCR and DNA-sequencing. We also characterized a collection of M. tuberculosis isolates
to see if Beijing strains had a higher rate of mutations in katG315, rpoB-RRDR region and embB306 gene. Multidrug-resistance was
observed to be significantly associated with Beijing strains (p=0.03) and a strong correlation between Beijing strains and specific
resistance mutations in katG315, rpoB 531 and embB306 gene segments was also found (p=<0.0001, <0.0001 & 0.0014 respectively).
These findings will help to understand the transmission and drug resistance related genetic characteristics of the Beijing/W genotype
of M. tuberculosis and may provide a scientific basis for the development of new TB diagnostic tool for effective management and
control of TB in countries with higher prevalence of Beijing strains.
Biography
Anamika Gupta has completed her PhD from Banaras Hindu University, India and Postdoctoral studies from National AIDS Research Institute, India. Currently, she is
working with Boston University School of Medicine as a Visiting Researcher. She has published 13 papers in peer reviewed journals and 5 manuscripts are in process. She
has also published 3 chapters in the books of international repute.
Anamika Gupta, J Infect Dis Ther 2016, 4:4(Suppl)